Fingerprint
Dive into the research topics of 'A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer
Barry Mirtsching, Thomas Cosgriff, Graydon Harker, Mark Keaton, Tarek Chidiac, Myo Min
Research output: Contribution to journal › Article › peer-review
61
Scopus
citations